ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CLGN vs LFWD // EV/EBITDA & P/E VALUATION

CollPlant Biotechnologies Ltd (NASDAQ) VS. Lifeward Ltd. (NASDAQ) • 15-METRIC TALLY: CLGN 3 — LFWD 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CLGN VS. LFWD) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CLGN LFWD SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 64.80% 96.00% -31.20 LFWD /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) 180.00% -17.60% +197.60 CLGN /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 4/9 +1.00 CLGN /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 56.3 44.8 +11.49 CLGN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $12.7M $16.7M -$4.1M LFWD /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CLGN REV LFWD REV CLGN GROSS % LFWD GROSS % CLGN FCF LFWD FCF
FY 2025 $2.4M $1.4M 64.8% 98.0% -$9.4M -$16.8M
FY 2024 $515.0K $1.7M -50.0% 98.0% -$14.6M -$21.7M
FY 2023 $11.0M $435.0K — — -$2.8M -$20.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CLGN // BETA —
LFWD // BETA —